hide message

Welcome to the Resource Centre

We make it our mission to work with advocates in civil society, business and government to address inequalities of power, seek remedy for abuse, and ensure protection of people and planet.

Both companies and impacted communities thank us for the resources and support we provide.

This is only possible because of your support. Please make a donation today.

Thank you,
Phil Bloomer, Executive Director

Donate now hide message

UN Human Rights Council urges flexibility in intellectual property rights to improve access to medicines

Get RSS feed of these results

All components of this story

Article
11 June 2013

Access to medicines in the context of the right of everyone to the enjoyment of the highest attainable standard of physical and mental health

Author: UN Human Rights Council

The Human Rights Council...Urges States...To promote access to medicines for all, including through the use, to the full, of the provisions of the Agreement on Trade-Related Aspects of Intellectual Property Rights which provide flexibility for that purpose, recognizing that the protection of intellectual property is important for the development of new medicines, as well as the concerns about its effects on prices;...To apply measures and procedures for enforcing intellectual property rights in such a manner as to avoid creating barriers to the legitimate trade of affordable, safe, efficacious and quality medicines, and to provide for safeguards against the abuse of such measures and procedures;...

Read the full post here

Article
13 June 2013

UN Human Rights Council Adopts Resolution Promoting Medicines Access

Author: Intellectual Property Watch

The United Nations Human Rights Council today adopted a resolution urging governments to encourage technology development and transfer and to apply intellectual property rights measures in ways that avoid creating barriers to trade in “affordable, safe, efficacious and quality medicines.” The resolution includes references to IP flexibilities in international trade law and to “delinkage” of R&D costs with the price of health products...Among its numerous provisions, the resolution reinforces countries’ right to use flexibilities to intellectual property rights as provided in the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS).

Read the full post here